Walleye Trading’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-3,300
Closed -$289K 6051
2021
Q3
$289K Buy
+3,300
New +$299K ﹤0.01% 3491
2020
Q3
Sell
-12,200
Closed -$711K 4756
2020
Q2
$711K Buy
+12,200
New +$656K ﹤0.01% 1965
2019
Q2
Sell
-15,300
Closed -$792K 4635
2019
Q1
$792K Buy
+15,300
New +$742K 0.01% 1876
2018
Q4
Sell
-2,600
Closed -$134K 5493
2018
Q3
$134K Buy
+2,600
New +$127K ﹤0.01% 4038
2018
Q2
Sell
-7,100
Closed -$252K 5014
2018
Q1
$252K Buy
+7,100
New +$278K ﹤0.01% 3280

Other funds holding SYNH

Walleye Trading's SYNH Position: Q3 2021 in Review

Walleye Trading sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2021, closing a stake of 799 shares — an estimated $72.3K sold.

Walleye Trading first reported a position in SYNH in Q4 2015 and held it in 7 quarters. The position peaked at $921K in Q3 2016. 355 funds tracked by Wall St. Rank hold SYNH as of Q3 2021.

  • Walleye Trading reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2021 after selling out during the quarter.
  • Walleye Trading sold 799 Syneos Health, Inc. Class A Common Stock shares in Q3 2021, an estimated $72.3K.
  • Walleye Trading first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2015 and held it in 7 quarters.
  • Walleye Trading's Syneos Health, Inc. Class A Common Stock position peaked at $921K in Q3 2016.
  • 355 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2021.

Based on Walleye Trading's 13F filing for Q3 2021, filed 15 Nov 2021.